Hypoglycemic Agents: all 3,927 studies that test it
Page 23 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.
- HbA1c Variability in Type II DiabetesActive, not recruitingNCT02879409Not applicable
- Apoptotic Signaling Pathways in Rats With Endometrial HyperplasiaCompletedNCT02872818Phase 4
- Influence of Central Nervous Insulin Sensitivity on Insulin SecretionCompletedNCT02870361Not applicable
- The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOSCompletedNCT02866786Phase 4
- Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 DiabetesCompletedNCT02866435Early Phase 1
- A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted ParticipantsCompletedNCT02865668Phase 1
- Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)CompletedNCT02857946Phase 1
- Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic TherapyCompletedNCT02855684Phase 3
- Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 DiabetesCompletedNCT02855307Phase 2
- A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes MellitusCompletedNCT02853630Phase 4
- Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular ResponseCompletedNCT02852486Phase 2
- A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLCStatus unknownNCT02852083Phase 2
- Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular GeometryCompletedNCT02851745Phase 3
- A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin Extended Release Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted ParticipantsCompletedNCT02851212Phase 1
- A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted ParticipantsCompletedNCT02851095Phase 1
- Prevention of Diabetes After Transplantation by Vildagliptin in the Early Post-transplant PeriodCompletedNCT02849899Phase 3
- The Effect of Metformin on Fecundability in an ART(Assisted Reproductive Technology) Setting - the Correlation to Uterine FlowsStatus unknownNCT02848950Phase 2
- Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up StudyWithdrawnNCT02848508Phase 2
- Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin TherapyCompletedNCT02847091Phase 4
- A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted ParticipantsCompletedNCT02846506Phase 1
- A Trial Investigating the Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart in Healthy Chinese SubjectsCompletedNCT02844790Phase 1
- Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)CompletedNCT02836704Phase 4
- Low dosE GlibENclamide in Diabetes Part ACompletedNCT02830048Phase 2
- Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and DyslipidemiaCompletedNCT02827903Phase 3
- CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)CompletedNCT02827890Phase 1
- Evaluation of Glycemic Changes During Exercise in Children With Type 1 DiabetesCompletedNCT02824510Not applicable
- The MetNET-2 TrialStatus unknownNCT02823691Early Phase 1
- Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY)CompletedNCT02816970Phase 1
- The Drug -Drug Interaction of SP2086 and GlyburideCompletedNCT02815787Phase 1
- The Drug-drug Interaction of SP2086 and MetforminCompletedNCT02813863Phase 1
- Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 WeeksTerminatedNCT02810483Phase 3
- Effects of Metformin Treatment on Myocardial Efficiency in Patients With Heart FailureCompletedNCT02810132Phase 2
- Topiramate and Schizophrenia: Effects on Weight and PsychopathologyActive, not recruitingNCT02808533Not applicable
- The Therapeutic Effects of Insulin and Berberine on Stress HyperglycemiaStatus unknownNCT02806999Phase 4
- Monotherapy With Rapamycin in Long-standing Type 1 DiabetesCompletedNCT02803892Phase 2
- The Effect of DPP4 Inhibitor on Vasclular HealingStatus unknownNCT02802644Phase 4
- Metformin for Prevention Gestational Diabetes in Pregnant Women With Polycystic Ovarian SyndromeStatus unknownNCT02802215Phase 2/3
- Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2CompletedNCT02798250Phase 2
- The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin MonotherapyCompletedNCT02798172Not applicable
- Metformin Pharmacokinetics in Patients With Chronic and Acute Heart FailureStatus unknownNCT02797340Phase 4
- The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 InhibitorsCompletedNCT02792400Not applicable
- A Study Assessing the Mass Balance of a Single Oral Dose of [14C] DS-8500a in Healthy SubjectsCompletedNCT02790684Phase 1
- A Study to Determine the Effects of Itraconazole on the Pharmacokinetics (PK) of DS-8500 in Healthy SubjectsCompletedNCT02790671Phase 1
- Metformin and Core Temperature in Obese and Lean MalesCompletedNCT02783053Not applicable
- Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBMActive, not recruitingNCT02780024Phase 2
- Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic SyndromeCompletedNCT02778776Phase 3
- Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy VolunteersCompletedNCT02777671Phase 1
- Closed-loop Control of Postprandial Glucose Levels After Meals With Different Macronutrients Content in Adults With Type 1 DiabetesCompletedNCT02774876Phase 2
- Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic SyndromeCompletedNCT02773927Phase 3
- The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End ProductsWithdrawnNCT02768220Phase 4
- Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW)Active, not recruitingNCT02767063Phase 1/2
- The Effects of Metformin on Glycemic Control and Insulin Sensitivity in Adolescents With T1DMCompletedNCT02765347Phase 4
- An Extension Study of PEAK TrialTerminatedNCT02763007Phase 4
- A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and MetforminCompletedNCT02760342Phase 1
- fMRI Study of Effects of Nasal Insulin on MemoryCompletedNCT02758691Phase 1
- Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer PatientsCompletedNCT02755844Phase 1/2
- Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mgCompletedNCT02753803Phase 1
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in JapanCompletedNCT02752828Phase 3
- Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic DrugsCompletedNCT02752412Phase 3
- Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 DiabetesCompletedNCT02752113Phase 3
- Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic AbnormalitiesCompletedNCT02751307Phase 4
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in JapanCompletedNCT02749890Phase 3
- Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) SecretionCompletedNCT02749032Phase 1
- Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy ParticipantsCompletedNCT02745912Phase 1
- Coronary Artery Disease Progression in Patients With PrediabetesCompletedNCT02744976Phase 4
- Drug Transporter Interaction Study PHENTRA_2015_KPUKCompletedNCT02743260Phase 4
- The Effect of Metformin on Reducing Lupus FlaresCompletedNCT02741960Phase 4
- Sulodexide Efficacy in Chronic Idiopathic Subjective TinnitusCompletedNCT02737670Phase 2
- Response of Individuals With Ataxia-Telangiectasia to Metformin and PioglitazoneCompletedNCT02733679Phase 4
- Glyburide vs Glucovance in the Treatment of GDMTerminatedNCT02726490Early Phase 1
- Incretin Axis in Type 1 Diabetes MellitusStatus unknownNCT02725502Not applicable
- Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes MellitusCompletedNCT02715193Phase 1
- Pharmacokinetic-Pharmacodynamic Relationship of Metformin in Healthy VolunteersCompletedNCT02712619Phase 1
- May Metformin be Used in Renal Failure?CompletedNCT02710448Phase 2
- Insulin in Total Parenteral NutritionCompletedNCT02706119Phase 4
- SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitisCompletedNCT02696941Phase 1
- Rosiglitazone Adjunctive Therapy for Severe Malaria in ChildrenCompletedNCT02694874Not applicable
- Effects of Metformin in Heart Failure PatientsWithdrawnNCT02694289Not applicable
- Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 DiabetesCompletedNCT02693392Not applicable
- Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOSCompletedNCT02689843Early Phase 1
- Safety and Efficiency Study of Pioglitazone in Combination With Imatinib Mesylate to Treat Chronic Myelogenous LeukemiaStatus unknownNCT02687425Phase 2
- Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.Status unknownNCT02685449Phase 4
- A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving SitagliptinCompletedNCT02685345Phase 2
- Mitochondrial-related Platelet Transcript Expression Levels in Pre-diabetic Subjects Randomized to Metformin or PlaceboCompletedNCT02682121Phase 1
- Accelerated Wound Healing in Diabetic Ulcers by SitagliptinWithdrawnNCT02675335Phase 3
- Metformin Plus Sorafenib for Advanced HCCStatus unknownNCT02672488Phase 2
- BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered AloneStatus unknownNCT02670018Phase 1
- An Exploratory Study of DS-8500a on Beta Cell Function Using Hyperglycemic ClampCompletedNCT02669732Not applicable
- A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mgCompletedNCT02659397Phase 2
- Metformin Immunotherapy in HIV InfectionCompletedNCT02659306Phase 1
- Effect of Sitagliptin on Progression of Coronary Intermediate LesionCompletedNCT02655757Phase 4
- TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.CompletedNCT02653209Phase 4
- A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver ResectionCompletedNCT02650427Phase 1
- SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLDCompletedNCT02649465Phase 4
- Assessing the Efficacy and Safety of Metformin in Treatment of Moderate PsoriasisStatus unknownNCT02644954Phase 3
- Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder PatientsCompletedNCT02644577Phase 4
- Migraine Treatment in EDWithdrawnNCT02643719Not applicable
- Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet FormulationsCompletedNCT02643329Phase 1
- Natriuretic Peptides and Metabolic Risk in ObesityWithdrawnNCT02642523Early Phase 1
- Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide AloneTerminatedNCT02640534Phase 2